CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at the Rodman & Renshaw Annual Global Investment Conference at 5:20 p.m. EDT (12:20 p.m. local time) on May 17, 2010, in London.
